Business Wire (Tue, 8:10AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (May 17, 2013)
-
Business Wire (May 15, 2013)
-
Business Wire (May 9, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (May 2, 2013)
-
Business Wire (Apr 25, 2013)
-
-
-
-
Business Wire (Apr 15, 2013)
-
-
-
Business Wire (Mar 20, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
Bullish on Acorda: New Drug Looks PromisingZacks Investment Research • Tue, Jun 23, 2009
-
Acorda Pops on Good NewsZacks Investment Research • Thu, May 7, 2009
-
-
Acorda Down on FDA DelayZacks Investment Research • Tue, Mar 31, 2009
-
-
Acorda Therapeutics: Sell or Short?Martin Roth • Mon, Oct 1, 2007 -
Loeb's Third Point LLC Lowering Its Stake in AcordaLon Juricic • Fri, May 25, 2007 -
Activist Hedge Fund Seeks Sale of AcordaCentient Biotech Investor • Sun, Feb 25, 2007 -
Acorda Therapeutics Responds to Loeb's Sale SuggestionLon Juricic • Sun, Feb 25, 2007
-
Acorda Therapeutics: Loeb's Third Point Urges Sale of CompanyLon Juricic • Fri, Feb 23, 2007
-
Eye on Acorda TherapeuticsAnthony Payne • Tue, Feb 20, 2007 -
-
-
-
-
-
-
-
-
-
-
-
6 Liquid Small-Cap Healthcare Stocks Projected For Strong GrowthZetaKap • Thu, Aug 30, 2012
-
-
-
6 Analyst Backed Small Cap Biotech Stocks With Plenty Of Cash CashZetaKap • Fri, Aug 3, 2012
-
7 Fast Growing Small Cap Biotech Stocks With Analyst ConfidenceZetaKap • Fri, Jul 6, 2012
-
-
-
-
6 Small Cap Stocks With Plenty Of Cash On Hand And Strong Expected GrowthZetaKap • Thu, May 24, 2012
-
6 High-Growth Biotech Stocks Analysts Rate As BuysZetaKap • Fri, May 18, 2012
-
Acorda Therapeutics CEO Discusses Q3 2010 - Earnings Call TranscriptMon, Nov 1, 2010
-
Acorda Therapeutics, Inc. Q2 2010 Earnings Call TranscriptTue, Aug 3, 2010
-
Acorda Therapeutics, Inc. Q1 2010 Earnings Call TranscriptFri, Apr 30, 2010
-
Acorda Therapeutics Inc. Q4 2008 Earnings Call TranscriptTue, Feb 24, 2009
-
Acorda Therapeutics, Inc., Q3 2008 Earnings Call TranscriptTue, Nov 4, 2008
-
Acorda Therapeutics, Inc. Q2 2008 Earnings Call TranscriptFri, Sep 5, 2008
-
Acorda Therapeutics Inc. Q1 2008 Earnings Call TranscriptMon, May 5, 2008
-
Acorda Therapeutics Q3 2007 Earnings Call TranscriptTue, Nov 6, 2007
-
Business Wire (May 17, 2013)
-
Business Wire (May 15, 2013)
-
Business Wire (May 9, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (May 2, 2013)
-
Business Wire (Apr 25, 2013)
-
at CNBC.com (Apr 15, 2013)
-
at CNBC.com (Apr 15, 2013)
-
Business Wire (Apr 15, 2013)
-
Business Wire (Mar 20, 2013)
-
Business Wire (Feb 25, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 14, 2013)
-
Business Wire (Feb 13, 2013)
ACOR vs. ETF Alternatives
Company Description
We are a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system. The first... More
